Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro

Journal of Virology

Volumn 76, Issue 9, 2002, Pages 4430-4440

  Feuer, Ralph ^a   Mena, Ignacio ^a   Pagarigan, Robb ^a   Slifka, Mark K ^a   Whitton, J Lindsay ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; GREEN FLUORESCENT PROTEIN; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; CELL CYCLE; CELL CYCLE PHASE; CHRONIC DISEASE; CONTROLLED STUDY; COXSACKIE VIRUS; COXSACKIE VIRUS B3; CYTOLYSIS; ENTEROVIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOSIS INHIBITION; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTIVITY; VIRUS LATENCY; VIRUS PATHOGENESIS; VIRUS REACTIVATION; VIRUS REPLICATION;

CELL CYCLE; CULTURE MEDIA; ENTEROVIRUS B, HUMAN; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; LUMINESCENT PROTEINS; RECOMBINATION, GENETIC; VIRUS ACTIVATION; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0036230175     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.9.4430-4440.2002     Document Type: Article

References (65)

1. Coxsackievirus B3 genomes detected by polymerase chain reaction: Evidence of latent persistency in the myocardium in experimental murine myocarditis
2. Molecular probes for detection of persisting enterovirus infection of human heart and their prognostic value
3. Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy
4. Evidence that human cardiac myocytes divide after myocardial infarction
5. Enterovirus sequences resembling coxsackievirus A2 detected in stool and spleen from a girl with fatal myocarditis
6. Helper T cell differentiation is controlled by the cell cycle
7. Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice
8. An approach to understanding the mechanisms of poliovirus persistence in infected cells of neural or non-neural origin
9. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: Localization to the 5′ nontranslated region
10. Virus infection as a function of the host cell life cycle: Replication of poliovirus RNA
11. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex
12. Translation initiation of the insulin-like growth factor I receptor mRNA is mediated by an internal ribosome entry site
13. Association of cap-binding protein with eucaryotic initiation factor 3 in initiation factor preparations from uninfected and poliovirus-infected HeLa cells
14. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis
15. Expression of an antigenic adenovirus epitope in a group B coxsackievirus
16. Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation
17. Cleavage of RasGAP and phosphorylation of mitogen-activated protein kinase in the course of coxsackievirus B3 replication
18. The 2A proteins of three diverse picornaviruses are related to each other and to the H-rev107 family of proteins involved in the control of cell proliferation
19. Mechanisms and consequences of enterovirus persistence in cardiac myocytes and cells of the immune system
20. Group B coxsackievirus infections in infants younger than three months of age: A serious childhood illness
21. Phosphorylation state of the cap-binding protein eIF4E during viral infection
22. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: Quantitative analysis of virus replication, tissue damage, and inflammation
23. The immune system in viral myocarditis: Maintaining the balance
24. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3
25. Delay of mengovirus-induced cytopathology in mitotic L-cells
26. The tyrosine kinase p561ck is essential in coxsackievirus B3-mediated heart disease
27. Persistent infection of human erythroblastoid cells by poliovirus
28. Cell cycle position and expression of encephalomyocarditis virus in mouse embryo fibroblasts
29. Enteroviral myocarditis and dilated cardiomyopathy: A review of clinical and experimental studies
30. There is no evidence for persistent enterovirus infections in chronic medical conditions in humans
31. Coxsackievirus infection of the pancreas: Evaluation of receptor expression, pathogenesis, and immunopathology
32. The role of B lymphocytes in coxsackievirus B3 infection
33. Perinatal echovirus and group B coxsackievirus infections
34. lck
35. There is evidence for persistent enterovirus infections in chronic medical conditions in humans
36. Growth factor-independent proliferation of erythroid cells infected with Friend spleen focus-forming virus is protein kinase C dependent but does not require Ras-GTP
37. o-like block leads to suppression of retinoblastoma protein expression
38. The role of myocarditis in end-stage dilated cardiomyopathy
39. S-phase-dependent cell cycle disturbances caused by Aleutian mink disease parvovirus
40. Viruses and the cell cycle
41. Transplanted adult bone marrow cells repair myocardial infarcts in mice
42. Persistent infection of K562 cells by encephalomyocarditis virus
43. Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis
44. A cell cycle-dependent protein serves as a template-specific translation initiation factor
45. 2/M cell cycle arrest requires sigmals and occurs in the absence of apoptosis
46. Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents
47. A cell cycle-dependent internal ribosome entry site
48. Cell cycle-dependent translational control
49. Coxsackieviruses and pancreatitis
50. Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells
51. Incidence of Coxsackie virus infection in patients with dilated cardiomyopathy
52. + T cells in controlling picornaviral infection
53. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors
54. Viral myocarditis: A paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy
55. Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts
56. Multiplication of Coxsackie B1 virus in synchronized HeLa cells
57. Strategies in subversion: De-regulation of the mammalian cell cycle by viral gene products
58. Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: Viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution
59. Duration of virus persistence and its relationship to inflammation in the chronic phase of coxsackievirus B1-induced murine polymyositis
60. Group B coxsackievirus myocarditis and pancreatitis: Connection between viral virulence phenotypes in mice
61. Genetics of coxsackievirus B3 cardiovirulence
62. Severe arrhythmias in Coxsackievirus B3 myopericarditis
63. Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: An approach to the study of enteroviral persistence in cardiac myocytes
64. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy
65. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure